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Abstract

Adult patients diagnosed with congestive heart failure suffer from high hospitalization rates,
recurrent readmissions, decreased quality of life, increased healthcare expenditures, and
increased mortality. This project aimed to determine if individualized coaching plans based on
patients’ activation scores impacted emergency room visits and hospital readmissions. A pretestposttest design was used. The 13-item Patient Activation Measure® (PAM®) tool was
administered before and after completing 30-day individualized coaching. Seventy-five
participants were recruited from referrals to the outpatient Continuum Case Management (CCM)
program. Inclusion criteria included English-speaking adult patients diagnosed with congestive
heart failure ≥ 18 years of age. The intervention consisted of individualized coaching
administered by the CCM registered nurse and community workers based on patients’ initial
activation scores. Chart reviews were conducted to determine if 30- and 90-day emergency room
(ER) visits and hospital readmissions were impacted. These data were compared to the prior sixmonth data for emergency room visits and readmissions of heart failure patients enrolled in the
CCM program. Pre and post-intervention activation levels were compared to determine the
impact of individualized coaching compared to standard care. Individualized patient-centered
care can reduce hospital readmissions and emergency room visits, improve quality of life, and
decrease healthcare expenditures.
Keywords: patient activation, congestive heart failure, readmissions, Patient Activation
Measure®, emergency room visits
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Patient Activation in Individualized Coaching for Congestive Heart Failure Patients
Hospitals are often measured by the quality of patient care. One of the ways this is
conducted is through the Hospital Readmissions Reduction Program by the Centers for Medicare
& Medicaid Services (CMS). This program incentivizes hospitals to improve quality by reducing
excessive readmissions in various health conditions, including congestive heart failure (Centers
for Medicare & Medicaid Services, 2020). Despite many advances in health care and technology,
excessive heart failure readmissions persist.
Background
Globally, cardiovascular disease is a leading cause of death for men and women of all
races (Centers for Disease Control and Prevention [CDC], 2020). Congestive heart failure, or
simply “heart failure,” occurs when the heart muscle cannot adequately pump, leading to blood
and fluid backing up into the lungs (Mayo Clinic, 2021). Heart failure is the leading cause of
hospitalization in the United States, plaguing 6.2 million and projected to rise by 46% by 2030
(CDC, 2020; American Heart Association News, 2017). Annually, the incidence increases by 5%
among those 85 years and older and 1.4% for ages 65 to 74 (Cajita et al., 2016).
In the United States, heart failure expenditures are estimated at $30.7 billion, and costs
for readmissions alone exceed $10 billion (CDC, 2020; Mirkin et al., 2017). Of Medicare
recipients, only 14% have a diagnosis of heart failure, but this accounts for 43% of total
expenditures (Husaini et al., 2016). Estimated yearly costs range from $21,300 to $52,800 per
patient (Groeneveld et al., 2019). Of patients with heart failure, over 20% are readmitted within
30 days of discharge and 50% at six months (O’Connor, 2017). Hospitalization due to heart
failure is a prognostic indicator of mortality. Heart failure, specifically, was the cause of death
for 379,800 Americans in 2018 (CDC, 2020). Stakeholders in heart failure readmissions include
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patients themselves due to the costs of frequent hospitalizations, testing, medications, devices,
management programs, decreased quality of life, and increased mortality. Additional
stakeholders include hospital systems penalized by frequent readmissions and reduced
reimbursement. Individualized patient-centered care has proven to be beneficial but is not
currently used to the fullest extent.
Problem Statement
Prevention of heart failure readmissions at Sentara Rockingham Memorial Hospital
(RMH) Medical Center was identified as a quality improvement goal. Within the Sentara system,
consisting of 12 North Carolina and Virginia hospitals, SRMH had the highest heart failure
readmission rate despite many new initiatives implemented to decrease this incidence over the
past several years. Continuum Case Management (CCM) is one example of a previously
implemented program to assist patients after discharge in preventing readmissions for heart
failure. This program is offered at no cost to participants to assist with disease coaching and
resource attainment. In 2020, a position for an inpatient heart failure nurse navigator was created
to identify patients admitted to the hospital in greatest need of reinforced education and
community services. In March 2021, Sentara RMH Medical Center opened its own nurse
practitioner-led heart failure clinic as an additional attempt to combat high readmissions rates.
Despite these initiatives, this location's high rate of heart failure readmissions persisted.
Currently, all patients followed by the CCM team receive inconsistent coaching based on the
nurse or community worker’s intuition. From July to December 2021, the 30-day heart failure
readmission rate for the CCM program was 22.2%, and the 30-day emergency room visit was
15.9%. In adult patients diagnosed with heart failure (P), does an individualized coaching plan
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using Patient Activation Measure® (I) compared to standard care (C) impact 30-day emergency
room visits and readmissions (O) over three months (T)?

Review of Literature
After conducting a thorough literature review of multiple research databases on
preventing heart failure readmissions, 16 articles supporting the use of patient activation and
individualized coaching plans for disease management were located. These articles are included
in Appendix A.
Patient activation measures an individual’s understanding, competence, and willingness
to participate in the care and treatment of a disease or health state (Hibbard et al., 2004). It is
utilized in various populations with acute and chronic illnesses but has been most studied in heart
failure (Dumitra et al., 2021; Mitchell et al., 2013). Other diseases including diabetes mellitus,
myocardial infarction, arrhythmias, congenital disease, coronary artery disease, asthma, chronic
obstructive pulmonary disease (COPD), hypertension, human immunodeficiency virus (HIV),
chronic kidney disease (CKD), depression, cancer, and stroke have also been studied (Cuevas et
al., 2021; Gholami et al., 2021; Kearns et al., 2020; Kinney et al., 2015; Lin et al., 2020; Roberts
et al., 2016).
The Patient Activation Measure® tool, created by Hibbard et al. (2004), and patented by
Insignia Health, utilizes a survey method to assess patient activation and places patients into four
levels ranging from low to high based upon score. The most utilized version of this tool is an
adapted 13-item version from the original 22-item tool (Cuevas et al., 2021; Dumitra et al., 2021;
Dunlay et al., 2017; Gholami et al., 2021; Jacobson et al., 2018; Kearns et al., 2020; Kinney et
al., 2015; Prey et al., 2016; Shively et al., 2013; Young et al., 2017). Since this has been the most
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studied version, the 13-item tool noted in Appendix B was chosen for implementation in this
project (Insignia Health, 2013). Other instrument variations have been utilized in research,
including 8-, 9-, and 10-item versions (Bishop Mc-Wain, 2019; Cuevas et al., 2021; Kinney et
al., 2015; Mitchell et al., 2013; Tecson et al., 2018).
Patients with lower identified activation levels tend to utilize the emergency room more
often and have higher rates of unplanned readmissions than those with higher levels of patient
activation (Dumitra et al., 2021; Prey et al., 2016). Studies have found a two-fold increased risk
of readmission in low-activated patients compared to those with a higher activation level
(Kinney et al., 2015; Mitchell et al., 2013). Being able to identify patients with low activation
enables the tailoring of interventions to decrease emergency room visits and patient readmissions
(Bishop-McWain, 2019; Dumitra et al., 2021; Kearns et al., 2020; Kinney et al., 2015; Mitchell
et al., 2013; Prey et al., 2016; Shively et al., 2013).
The patient activation score is used to tailor individual coaching sessions to improve
activation and self-management ability and decrease emergency room visits and readmission
rates. Activation scores assessed at baseline identify individual patient activation levels seen in
Appendix C (Insignia Health, 2013). Coaching plans, individualized for each of the four levels of
patient activation, aim to increase patient activation in low-activated patients and increase selfmanagement in patients with heart failure (Dumitra et al., 2021; Lin et al., 2020; Young et al.,
2017). Self-management is found to positively correlate with the levels of patient activation
(Gholami et al., 2021; Jacobson et al., 2018; Lin et al., 2020; Young et al., 2017). Those with
higher activation levels tend to have greater self-management, including medication adherence,
proper diet, exercise, and self-weighing (Kearns et al., 2020; Lin et al., 2020; Young et al.,
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2017). Greater adherence to disease management decreases emergency room utilization and
prevents hospital readmissions.
Theoretical Framework
The theoretical framework used to address this phenomenon of interest was Afaf Meleis’
Transitions Theory. This theory recognizes that changes in health and illness create a transition
process in the patient’s life, posing additional risks to their health or enhancing their well-being
(Meleis et al., 2000). Periods of transition increase a patient’s vulnerability to experiences,
interactions, and environmental conditions leading to extended recovery, potential damage, and
delayed or unhealthy coping. This theory has been used to describe illness experiences, including
diagnosis, surgery, rehabilitation, and lifespan transitions, such as pregnancy, childbirth, aging,
and death (Meleis et al., 2000). The transitions theory framework has been applied to reduce 30day readmission rates in Medicare and Medicaid patients by creating a care coordination team,
reducing readmissions by 11% (Stixrood, 2019). There are two parts to Afaf Meleis’ Transitions
Theory: intervention and understanding the transition experience (School of Nursing, n.d.). An
intervention facilitates the transition and promotes well-being. The goals are to provide
knowledge, skills, strategies, and psychosocial support to endure the transition (School of
Nursing, n.d.). The transition experience depends on developmental, health and illness,
situational, and organizational triggers. The health-illness transition is defined by a person
progressing from a healthy to acute or from a healthy to a chronic state. The healthy, acute, and
chronic states fluctuate on a continuum with exacerbations and disease progression.
Receiving a diagnosis of a chronic illness such as congestive heart failure prompts a life
transition. The patient will require ongoing coaching regarding lifestyle changes, medications,
continuous follow-up, treatment, and disease progression from a state of health to illness. The
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patient will also experience acute exacerbations of their chronic disease, possibly requiring
hospitalization. Upon discharge from the hospital, the patient will transition back into a healthy
state if the disease is controlled. In addition to addressing the needs of the disease process, this
framework was utilized to address psychosocial needs. A heart failure diagnosis can lead to a
decrease in quality of life. Some patients entering the CCM program have a new diagnosis of
congestive heart failure and may be experiencing the transition from a healthy to a chronic
disease state.
Project Purpose, Objectives, Expected Outcomes
This project aimed to identify the level of patient activation utilizing the Patient
Activation Measure® tool and to provide tailored individualized coaching. The goals were to
improve patient activation and self-management ability allowing patients to understand their
disease, demonstrate competence, and increase willingness to participate in their care and
treatment. Expected outcomes were to decrease emergency room visits and readmissions and
increase patient activation by providing individualized coaching.
Project Design
Sentara Rockingham Memorial Hospital Medical Center (SRMH) is a 238-bed, not-forprofit community hospital partnered with Sentara Healthcare in Harrisonburg, Virginia. The
hospital serves approximately 218,000 residents from seven counties in Virginia and rural West
Virginia (Sentara, 2021). Heart failure services include cardiac imaging, cardiac catheterization,
cardioMEMS monitoring implantation, and follow-up in the heart failure clinic. Before
discharge, inpatient care coordinators and the heart failure nurse navigator arrange follow-ups
with Sentara Cardiology and place referrals to the outpatient Continuum Case Management team
consisting of community workers and registered nurses. Before this project, all patients followed
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by the CCM team received inconsistent coaching based on the registered nurse or community
workers’ intuition of patient needs.
Heart failure readmissions impact all genders and races nationwide and globally. It is
most common in rural, poor areas, among the elderly, and minority populations. Male gender,
African American race, and those receiving Medicare benefits are at the highest risk of
readmission (Mirkin et al., 2017). In Virginia, heart disease is the second leading cause of death,
accounting for 14,861 deaths in 2017 (Centers for Disease Control and Prevention, 2018). The
highest rate of heart disease deaths occurs in southwest Virginia. In Rockingham County, the
location of Sentara RMH Medical Center, heart disease mortality rates are 275 per 100,000 for
those 35 years of age and older for both genders and all races (Virginia Department of Health,
2021). Men have higher rates (347 per 100,000) compared to women (214 per 100,000), and
African Americans of both genders have the most heart disease mortality in Rockingham County
(330 per 100,000). The target population for this project included all English-speaking patients
diagnosed with congestive heart failure over 18 years of age who were referred to the CCM
program. This project used an evidence-based tool for a quality improvement initiative and
consisted of 75 participants as required by Insignia Health for using the PAM® tool.
Implementation Plan/Procedures
Project Method/Model
While Afaf Meleis’ Transitions Theory best addressed the psychosocial needs of heart
failure patients, the model utilized to guide the implementation of this project was the Institute
for Healthcare Improvement’s Model for Improvement (MFI). This model, developed in 1996, is
the most commonly used in quality improvement initiatives. The MFI is composed of two parts:
three fundamental questions and the Plan, Do, Study, Act (PDSA) cycle created by Dr. William
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Edwards Deming (Agency for Healthcare Research and Quality [AHRQ], 2013; Institute for
Healthcare Improvement [IHI], 2021). The MFI asks three questions: What are we trying to
accomplish? How will we know that a change is an improvement? What changes can we make
that will result in improvement? The PDSA cycle evaluates the effects of changes through
planning, trying, observing, and acting on what is learned (IHI, 2021).
Implementation Steps
In the pre-planning stages, the three fundamental questions of the Model for
Improvement were answered. The goal was to impact heart failure readmissions and emergency
room visits using a tailored coaching program directed by patient activation levels obtained using
the Patient Activation Measure®. An improvement would be noted by observing a decrease in
emergency room visits and readmissions and increased patient activation scores. A change was
made by tailoring coaching based on patient activation, and this concept can be applied to other
patient populations with acute and chronic diseases.
The planning phase of the PDSA cycle included gaining project site support, SRMH
Evidenced-Based Practice & Research Council approval, SRMH and the University of South
Carolina Institutional Review Boards’ (IRB) permission, and approval from Insignia Health to
use the Patient Activation Measure®. The heart failure nurse navigator, registered nurses, and
community case workers within the CCM program were trained to provide the PAM-13® survey
and coaching based on activation level. Emergency room visits, readmissions, and trends in
patient activation scores were observed.
Measures, Tools, and Data Plan
Demographic information, including age, gender, education level, and marital status,
were obtained from the Epic electronic health record (EHR) system. Patient activation scores
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were obtained using the 13-item Patient Activation Measure® by Insignia Health. Participant allcause emergency room visits and readmission data were extracted via manual chart review from
the Epic EHR. The heart failure nurse navigator and continuum care team administered the tool
upon enrollment in the CCM program and 30-days post-coaching. Respondent’s answers to the
PAM® tool were entered into an Excel software program provided by Insignia Health to
calculate activation levels. Following calculation, individual levels were shared with the
continuum care registered nurses and community health workers, but not the patients themselves
so as not to introduce bias. Based on activation level, patients underwent level-specific coaching
adapted from Shively et al. (2013) by the CCM registered nurses and health workers focusing on
self-management, confidence & knowledge, skills & behavior, and skills & behavior in other
situations as depicted in Appendix D. Over the project's duration, outcomes of 30-day emergency
room visits and readmissions were monitored as required by Insignia Health. The Centers for
Medicare and Medicaid Services (CMS) monitors all-cause 30 and 90-day readmission data;
therefore, the frequency of data monitoring follows that of CMS. Since participants entered the
CCM program on rolling enrollment, data was measured at a minimum of 30 days and a
maximum of 90 days as able. A t-test was conducted on pre- and post-activation scores, and
analysis of variance (ANOVA) testing was conducted between demographic variables and initial
activation scores and between activation level and 30- and 90-day emergency room visits and
readmissions.
Timeline
Project approval was sought and obtained from SRMH’s Evidence-Based Practice and
Research Shared Governance Council on October 14, 2021. Before obtaining IRB approval from
SRMH and the University of South Carolina, a research license was obtained from Insignia
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Health on December 31, 2021. Training was provided to the heart failure nurse navigator who
administered the initial PAM® survey. After all IRB approvals were obtained, the first
participant was enrolled in the project on January 27, 2022. Training was provided to the CCM
nurses and community workers the following day. The final participant was administered the
PAM® survey and enrolled in the project on June 3, 2022. The complete timeline for this project
is noted in Appendix E.
Budget/Resource Requirements
A research license fee of $150 was paid to Insignia Health for using the PAM® tool.
Since the Continuum Case Management program is offered to patients at no cost, the benefits of
preventing future heart failure readmissions outweighed the cost of using the tool in this project.
Patients benefit from decreased cost of frequent hospitalizations, emergency room visits, testing,
increased quality of life, and decreased mortality. The nursing profession benefits from providing
high-quality, evidence-based, patient-centered care. Sentara RMH Medical Center benefits from
decreased costs and resource utilization endured from frequent readmissions and emergency
room visits.
Protection of Human Subjects
Institutional Review Board approval from Sentara RMH Medical Center and the
University of South Carolina was obtained before initiating this quality improvement project. All
participants were protected by the Health Insurance Portability and Accountability Act (HIPAA).
The risk to participants in this study did not differ from patients receiving current coaching. All
data was stored on the secure, password-protected Research Electronic Data Capture (REDCap)
application. The REDCap software is HIPAA-complaint and was available at no cost through the
University of South Carolina. Confidentiality was ensured by coding participants using personal
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identification numbers. Completed paper questionnaires were stored in the locked office of the
quality improvement coordinator. Participants’ answers and patient activation scores were stored
in a password-protected Excel file. De-identified results will be shared with Insignia Health as
required for using the PAM® tool. A USB drive containing backup files was stored in a
password-protected safe. Only the researcher and project chairs had access to passwords and
patient information. Informed written consent was obtained from all participants in the project.
Results
Statistical analyses were conducted using Intellectus Statistics software (2019). The table
of descriptive statistics is found in Appendix F. The final sample population included 75
participants, 29 male (38.67%) and 46 female (61.33%). Participants’ ages ranged from 33 to 95
years; 44% were married, and 56% were single, divorced, or widowed. Education level was not
consistently documented and was excluded from statistical testing. Among the participants, 11
were readmitted within 30 days, and one was readmitted twice within the same time frame.
During the measurement period, 16% of participants also had a 30-day emergency room visit.
Due to the rolling enrollment design of the project, a complete 90-day follow-up was only
possible for 34 of the total 75 participants. Of these, one person had a 90-day readmission, one
had two 90-day readmissions, and one had three 90-day readmissions. Of the participants, five
people had one 90-day emergency room visit, and two participants each had two visits. The 30day readmission rate for this sample was 17.3%, which was lower than six months before the
implementation of this project for the CCM program, which was 22.2%. The 30-day emergency
room visit rate was 16%, similar to the 6-month prior rate of 15.9%.
All participants had initial PAM® levels calculated when they agreed to participate in the
project and CCM program. The most common initial PAM® level was 3 (n=34), followed by 2
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(n=20). Levels 1 and 4 were relatively similar: 1 (n=10) and 4 (n=11). Following the initial
survey, 28 participants were lost to follow-up due to declining the CCM program after initially
agreeing. Three additional participants were discharged to a skilled nursing facility instead of
home, making them ineligible for participating in the program. The mean score of initial PAM®
levels was 2.50, while the mean for re-survey levels was 2.91, as noted in Appendix G (Figure
G1).
A two-tailed paired samples t-test was conducted to compare initial PAM® levels to resurvey PAM® levels completed 30-days after starting the CCM program (Table G1). Testing
concluded there was a statistically significant difference between the two. The re-survey PAM®
scores were significantly higher than the initial scores. A Shapiro-Wilk test indicated the
normality assumption was violated, so a Wilcoxon Signed Rank test was also performed since it
does not share distribution assumptions. The two-tailed Wilcoxon Signed Rank test result was
significant, indicating that the differences between initial PAM® scores and re-survey scores
were not due to random variation. The median scores of the re-survey PAM® level were
significantly higher than the median initial scores (Figure G2).
One-way analysis of variance (ANOVA) testing was conducted to determine if a
significant correlation existed between initial PAM® levels, demographic variables, 30-day ER
visits, 30-day readmissions, 90-day ER visits, and 90-day readmissions (Appendix G). Mean
PAM® levels by individual demographic variable are also noted. There was no significant
difference in PAM® levels among marital status, age, gender, 30-day readmissions, 30-day ER
visits, or 90-day readmissions (Tables G2-G15). There was a significant correlation between
PAM® level and 90-day emergency room visits (Tables G16-G17, Figure G3). Those with two
90-day ER visits had a significantly lower mean PAM® score than those with one or no ER
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visits. Education level correlation cannot be considered reliable due to incomplete data available
for 57 participants.
The steps of the intervention can be noted in Appendix H. In the initial plan, the CCM
registered nurse was to administer the initial survey to the participant upon enrollment. The
initial administration of the survey was modified to be performed by the navigator since the heart
failure nurse navigator position was filled before this project's implementation. Most referrals to
the CCM program are from this position, and the navigator is the first point of patient coaching.
Once PAM® levels were calculated, the CCM community workers and nurses utilized the plan
outlined in Appendix D for individualized coaching with participants. After initially accepting,
those who refused the CCM program were lost to re-survey follow-up but were included in the
chart review for demographic information, 30- and 90-day readmissions, and 30- and 90-day
emergency room visits. Due to rolling enrollment in the CCM program, 90-day readmission and
90-day emergency room visit data could not be obtained on all participants. The projected
timeline for this project was for completion within three months. Due to the sample size
requirement of 75 participants, it was conducted over approximately six months.
Discussion
The CCM program serves not only heart failure patients but also those with chronic
diseases, including chronic obstructive pulmonary disease (COPD) and diabetes mellitus. The
Patient Activation Measure® has been applied in other studies to various populations both in the
inpatient and outpatient settings. The future direction of this project includes individualized
coaching based on initial patient activation levels for increased self-management ability allowing
patients to understand their disease, demonstrate competence, and improve willingness to
participate in their care and treatment in other patient populations. Allowing care to be
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individualized to each patient’s needs will enable them to make sustainable lifestyle changes,
medication adherence, follow-up, and understand treatments and disease progression.
Prior studies indicated that patients with lower identified activation levels tended to
utilize the emergency room more often and have higher rates of unplanned readmissions than
those with higher levels of patient activation (Dumitra et al., 2021; Prey et al., 2016). Although
no statistically significant correlation was found between initial patient activation level and 30and 90-day readmissions and 30-day emergency room visits, small sample size may have
impacted these results. Among the 75 participant sample, the most common initial PAM level®
was 3 (n=34), meaning they were “taking action and gaining control” before any intervention.
Those with a PAM® score of 3 are already at low risk for ER utilization and readmissions. The
male gender was previously implicated as an increased risk for readmission. The sample size for
this project was predominately female (46) compared to male (29).
This project impacts patients with not only congestive heart failure but also hospital
systems and the healthcare burden. Patients are affected due to the costs of frequent
hospitalizations, testing, medications, devices, management programs, decreased quality of life,
and increased mortality. Patient satisfaction and empowerment to take control of their health are
also impacted. Hospital systems are penalized by frequent readmissions and reduced
reimbursement. The average 30-day heart failure readmission cost at Sentara RMH Medical
Center in 2021 was $14,696. A 4.9% decrease in 30-day heart failure readmissions was noted
between the six months before and during the project measurement period. The potential for cost
avoidance due to the decreased readmission rate is evident. This reduction in readmission rate
also carries a reduced risk for CMS penalty due to excessive heart failure readmissions, which
brings an additional 3% cost savings.
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Several strengths can be drawn from this project. One strength is that the Patient
Activation Measure® can be utilized in various patient populations and is not limited to heart
failure. Using the patient’s initial PAM® score provided guidance for the CCM team on
coaching. A 4.9% decrease in 30-day readmissions was noted as a result of this project. While
this percentage may seem small, the cost avoidance of even a few heart failure readmissions
makes a significant impact. CMS penalizes hospital systems for excessive heart failure
readmissions. This penalty is also avoided with any decrease in the readmission rate. The validity
and reliability of the PAM® tool are evident from the various studies conducted since its creation
in 2004. Since then, it has been patented and is marketed with a commercial license available for
its use.
A limitation of the project was staff turnover before and during implementation. The time
frame allowed for implementation was another limitation. Participants were enrolled on rolling
enrollment, and due to time constraints, all participants were not coached and monitored for
equal amounts of time. Data on 90-day emergency room visits and readmissions were
unavailable for all participants. Another limitation is missing data if participants visited urgent
care centers or outside facilities during the project; this information is not available in the Epic
EHR. The small sample size was another limitation. Although 75 participants were initially
enrolled, the minimum required by Insignia Health, 31 were lost to follow-up due to declining
the program or being discharged to a skilled nursing facility after initially agreeing to participate.
Data entry into REDCap and the PAM® Excel calculator was a manual process; therefore, the
risk of entry error is possible. A double-check of all manually entered data was conducted. The
pre/post format of the project could have induced bias since the same questions were used in
both survey evaluations.
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Conclusion

Individualized coaching performed by the CCM team and heart failure nurse navigator is
evident in the impact on re-survey patient activation scores. Although statistically significant
results on 30- and 90-day readmissions and 30-day emergency room visits were not seen in this
sample population, the impact on a larger population is evident by a reduction in cost avoidance.
The results of this project will be disseminated to Insignia Health as a requirement for using the
Patient Activation Measure®. Dissemination will also likely include publication in a peerreviewed case management or nursing journal, shared with the CCM team, SRMH leadership
and management, and the SRMH Evidence-based Practice and Research Council. If hospital
leadership sees the Patient Activation Measure® as a tool they would like to continue using,
further steps include SRMH purchasing a commercial license for implementation.
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Appendix A
Literature Review Table

Brief Reference, Type of Study,
Quality rating
Article 1: Lin, M. Y., Weng, W. S.,
Apriliyasari, R. W., Van Truong, P., &
Tsai, P. S. (2020). Effects of patient
activation intervention on chronic
diseases: a meta-analysis
Evidence Level: I – Systematic review
of RCTs with meta-analysis
Quality: A – High quality, generalizable
results, definitive conclusion, consistent
recommendations, comprehensive
literature review

Methods
Design: Systematic review
with meta-analysis
Sample: 26 randomized
control trials, English &
Chinese language, adults ≥
18 yrs.
Setting: 13-United States,
4-Europe, 2-Taiwan, 2-Iran,
2-China, 1-South Korea, 1Australia, 1-Thailand
Framework: N/A
Measures: Patient
activation interventions on
physiological,
psychological, behavioral,
and health-related quality of
life outcomes
Analysis Plan: Cochrane
Handbook to assess the
methodological quality of
RCTs, Hedge’s g values,
95% confidence interval.
Procedure: Systematic
search of PubMed,
Cochrane, CINAHL,
Embase databases

Threats to Validity/
Reliability
Conclusion Validity:
Reasonable, some
relevant studies were
excluded due to lack
of medical subject
headings; limited
effect could be due to
number of studies.
Internal Validity:
Intervention designs
and types of disease
varied, significant
heterogeneity.
External Validity:
Studies conducted in
variety of settings in
several countries.
Construct Validity:
ok. Measurements
may vary based on
diagnosis.
Reliability: Applied
across variety of
physiologic,
psychologic, behavior
and QOL
measurements
Precision:
Statistically
significant pooled
effect for HbA1C,
SBP, DBP, body
weight, LDL,
depression, anxiety;
no statistically
significant differences
between intervention
types.

Study Findings
Patient activation on HbA1C had
effect size of -0.31 (p<.01), small
effect.
Patient activation on SBP small
effect, -0.21 (p<.01), but large
effect on DBP, -0.80 (p=.02).
Activation on body weight had
small effect, -0.12 (p=.03).
Activation on LDL had small
effect, -0.21 (p=.01).
Activation on depression had
small effect, -0.16, (p<.01).
Activation on anxiety had small
effect, -0.25, (p=.01).
Patient activation interventions
on activation had small effect,
0.33, (p<.01).
Activation on self-efficacy had
medium effect, 0.57 (p<.01).
Activation on health-related QOL
had small effect, 0.25, (p=.01).

Conclusions
Patient activation interventions
significantly improve
physiological, psychological, and
behavioral health statuses.
Patient activation interventions are
effective in improving quality of
life in patients with chronic
diseases.
Healthcare providers should
implement interventions that are
tailored to patients’ level of
activation.
Patients who are more activated
are more likely to engage in selfmanagement behaviors and
improve health.
A multimodal approach to disease
management is needed to effect
care outcomes in patients with
chronic diseases.
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Brief Reference, Type of Study,
Quality rating
Article 2: Mitchell, S. E., Gardiner, P.
M., Sadikova, E., Martin, J. M., Jack, B.
W., Hibbard, J. H., & Paasche-Orlow, M.
K. (2013). Patient activation and 30-day
post-discharge hospital utilization.
Evidence Level: I – Randomized
Control Trial
Quality: A – High quality – consistent,
reasonably generalizable results,
adequate control, definitive conclusions,
consistent recommendations, large
sample size

26
Methods
Design: Secondary analysis
of RCT
Sample: 695 general
medical inpatients, English
speaking, with complete
data from RED-LIT trials
Setting: Medical inpatient
service at Boston Medical
Center, an urban safety net
hospital
Framework: N/A
Measures: 30-day postdischarge emergency
department visits, hospital
readmissions, observational
stays
Analysis Plan: Chi-square
tests, 95% confidence,
Poisson regression, twosided tests, p<0.05.
Procedure: Modified 8item Patient Activation
Measure® at baseline during
index hospitalization

Threats to Validity/
Reliability
Conclusion Validity:
Reasonable, number
of patient-level
variables controlled
for many potential
confounders.
Internal Validity:
Adjustment for
confounding variables
still indicated
statistically significant
results.
External Validity:
Study conducted in
safety net hospital,
may not be
generalizable.
Universal insurance in
Massachusetts may
limit generalizability.
Construct Validity:
Missing reutilization
data from outside
Boston Medical
Center, obtained by
medical record and
self-report.
Reliability:
Questionable. PAM-8
has not been fully
tested for reliability &
validity.
Precision:
Statistically
significant results for
PAM score on
primary and secondary
outcomes, 95%
confidence interval.

Study Findings
Significant associations between
patient activation (levels 1 and 2)
and education (p=.01),
employment status (p=.02),
health literacy level (p<.01), and
depressive symptom level
(p<.01).
Lowest PAM score (level 1) has
2.27 times risk of reutilization
within 30-days (95% CI, 1.563.30, p<.001).
Level 2: 1.78 times risk of
reutilization within 30-days (95%
CI, 1.28-2.49, p<.001).
Level 3: 1.42 times risk of
reutilization within 30-days (95%
CI, 1.04-1.95, p=.03).

Conclusions
Lower levels of patient activation
had higher rates of post-discharge
30-day hospital utilization.
Hospitals in 25 states use the
Patient Activation Measure to
tailor type and amount of support
provided to patients during
hospitalization and post-discharge.
Transition care teams should use
PAM to segment patient
populations based on disease
burden and ability to self-manage
(PAM-score) –focus on low levels
of activation.
Greater access to health services is
not sufficient to reduce avoidable
readmissions; resources need to be
tailored to the patients’ individual
needs and activation level.
This study was included because it
was the first to examine the role of
patient activation on the rate of
hospital readmission within 30days of hospital discharge.
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Brief Reference, Type of Study,
Quality rating
Article 3: Shively, M. J., Gardetto, N. J.,
Kodiath, M. F., Kelly, A., Smith, T. L.,
Stepnowsky, C., Maynard, C., & Larson,
C. B. (2013). Effect of patient activation
on self-management in patients with
heart failure.
Evidence Level: I – Randomized
Control Trial
Quality: B – Good quality – reasonably
consistent results, some control, small
sample size but sufficient for this study,
fairly definitive conclusions, reasonably
consistent recommendations

27
Methods
Design: Stratified blocked
randomized, 2-group (usual
care, usual + 6 month
activation/Heart PACT
intervention), repeated
measures.
Sample: 84 participants,
≥18yrs., live in San Diego
County, read/speak English,
telephone access, has PCP.
Setting: Single site
affiliated with Veterans
Affairs (VA) San Diego
Healthcare System
Framework: N/A
Measures: Patient
activation, self-management,
hospitalizations, ED visits
Analysis Plan: ANOVA for
main effects and interaction
effects, Little’s MCAR test,
F test.
Procedure: 13-item Patient
Activation Measure (PAM),
Self-Care and Heart Failure
Index (SCHFI) version 4 &
Medical Outcomes Study
Specific Adherence Scale,
patient self-reported
hospitalizations, ED visits,
other unscheduled visits

Threats to Validity/
Reliability
Conclusion Validity:
Small sample size
(84), some significant
effects showed
observed power less
than 0.80.
Internal Validity:
Age/gender
demographics,
attrition (19%) at 6
months, missing data,
clinical practice
changes during study,
gasoline prices caused
transportation issues.
External Validity:
Predominately male
sample-may be gender
differences, VA
system may not be
generalizable to
private sector.
Construct Validity:
Measured as stated but
small number of
hospitalizations & ED
visits during study.
Reliability: Prior to
this study, there were
no published reports
of PAM use and links
between behaviors &
patient outcomes.
Precision:
Statistically
significant increase in
activation/PAM from
baseline to 6-months
(F=3.73, P=.03).

Study Findings
Significant group-byactivation/PAM level-by-time
interaction (F=3.89, P=.005).
Intervention group improved
more over time than usual care
(control).
No significant group-by-time
interactions for the SCHFI
maintenance, management, or
self-confidence scales.
Significant increase in
activation/PAM from baseline to
6-months (F=3.73, P=.03).
Baseline MOS Specific
Adherence Scale mean was lower
in the intervention group with
significant group-by-time effect
(F=7.48, P=.001). Intervention
group improved more than usual
care.
Significant 3-way interaction for
hospitalizations (F=2.57,
P=.041). Intervention group had
fewer hospitalizations than usual
care when baseline PAM was low
or high.
Intervention showed increased
perceived control scores at 6months compared to usual care
(F=3.23, P=.015).

Conclusions
This study was included because it
is one of the first on efficacy of an
activation intervention in patients
with chronic HF.
Patient activation can be improved
through targeted interventions.
Effect was more pronounced in
people with medium level of
baseline activation.
Activation interventions supports
previous research showing changes
on level of activation accompanied
by changes in self-management
behaviors.
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Brief Reference, Type of Study,
Quality rating
Article 4: Young, L., Kupzyk, K., &
Barnason, S. (2017). The impact of selfmanagement knowledge and support on
the relationships among self-efficacy,
patient activation, and self-management
in rural patients with heart failure.
Evidence Level: I – Randomized
Control Trial
Quality: A – High quality – Consistent,
generalizable, sufficient sample size,
adequate control, definitive conclusions,
consistent recommendations.

28
Methods
Design: Secondary analysis
of Randomized Control
Trial
Sample: 100 adults ≥
21yrs., discharge diagnosis
of HF, NYHA class I w/ at
least 1 HF-related
hospitalization or ED visit in
past year, NYHA class II to
IV, discharged to home,
English-speaking, access to
telephone, data from
“Patient Activated Care at
Home (PATCH)” RCT.
Setting: Rural hospital in
Southeast Nebraska
Framework: Wagner’s
Chronic Care Model
Measures: Selfmanagement (SM)
knowledge, self-efficacy,
patient activation, and selfmanagement behaviors at
baseline, 3- and 6-months
after intervention
Analysis Plan: ShapiroWilk for normality. Pearson
correlations & linear
regression, P < .05
Procedure: Self-care of HF
Index (SCHFI) Subscale C –
self-efficacy, 13-item
Patient Activation
Measure® (PAM), Heart
Failure Self-Care Behavior
Scale (RHFSCBS) in
control and 12-weeks homebased intervention to
improve SM behavior group

Threats to Validity/
Reliability
Conclusion Validity:
Convenience
sampling, adequate
sample size (medium
effect n=98, r=0.3, 5%
α=.05, 80% power).
Internal Validity:
selection bias,
enrolled patients may
have more confidence
and are actively
engaged in SM
behaviors.
External Validity:
participant recruitment
results in selection
bias, more female
subjects than male
Construct Validity:
Complexity not
adequately capturedmeasures of SM
knowledge and
support were
rudimentary and
heterogenous.
Reliability: Feasible
& effective to improve
SM behaviors & needs
in vulnerable & highrisk population
Precision: Significant
bivariate correlations
between education
level, physical
functioning, SM
knowledge, and
support at baseline
and 3-months.

Study Findings
Factors related to baseline & 3
month activation scores:
education, physical functioning,
SM knowledge & support.
Patient activation mediated effect
of self-efficacy on SM behaviors
with low levels of knowledge.
Self-efficacy had significant
association with patient
activation (𝛽=.48, P<.001).
3-month post-intervention, selfefficacy for SM was positively
related to patient activation
(r=0.712, P<.001) and SM
behaviors (r=0.46, P<.001).
Patient activation significantly
associated with SM behaviors
(r=0.528, P<.001).
Patients with greater self-efficacy
more likely to engage in SM
behaviors (r=0.46, P<.001).
Intervention group who received
12-week activation-enhancing
program showed significantly
greater activation scores at 3
months.

Conclusions
Low SM knowledge & poor
support should be targets for
patient activation intervention.
Self-efficacy leads to changes in
patient activation, which leads to
changes in SM behaviors.
Patient activation mediates the
relationship between self-efficacy
and SM behavior.
Patients with high levels of SM
knowledge, neither self-efficacy
nor patient activation accounted for
behavioral changes.
In patients with low required
support, confident patients (higher
self-efficacy) were more likely to
engage in SM behaviors.
If patients receive greater support,
they are more likely to engage in
SM behaviors, regardless of
activation and self-efficacy.
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Brief Reference, Type of Study,
Quality rating
Article 5: Cuevas, H., Heitkemper, E.,
Huang, Y. C., Jang, D. E., García, A. A.,
& Zuñiga, J. A. (2021). A systematic
review and meta-analysis of patient
activation in people living with chronic
conditions.
Evidence Level: II – Systematic review
of a combination of RCTs and quasiexperimental studies with meta-analysis
Quality: B – Good quality – Reasonably
consistent, generalizable results,
sufficient article sample size for
systematic review, insufficient
population sample size for RCTs,
comprehensive literature review

29
Methods
Design: Systematic review,
meta-analysis
Sample: 9069 participants,
ages 40.8-74.0. 32 articles:
English language, peerreviewed, adults ≥ 18 yrs.,
at least 1 chronic condition,
assessment of patient
activation, one-disease
relevant self-management
behavior published after
2005.
Setting: 20 – United States,
5 – United Kingdom, 3 –
Norway, 2 -Netherlands, 1 –
Spain, 1 - Singapore
Framework: N/A
Measures: Patient
activation using PAM tool
on interventions-group (8),
in-person one-on-one
coaching (9), telehealth (8).
Analysis Plan: Preferred
Reporting Items for
Systematic Reviews and
Meta-Analysis (PRISMA),
Cochrane Review Manager
(version 5.3) used for metaanalysis.
Procedure: PubMed,
CINAHL, & Web of
Science databases searched
using MeSH: patient
activation, self-management,
intervention during
December 2019.

Threats to Validity/
Reliability
Conclusion Validity:
Small sample size in
RCTs
Internal Validity: No
attention to control
group, this would
address equal
treatment of groups
evaluating effects of
behavioral
interventions. Lack of
diversity in the
samples.
External Validity:
Low income, less
education, poorer
reported health will
have low activation
levels – focusing only
on activation will not
address disparities.
Construct Validity:
Considerable
heterogeneity –
various methods of
patient activation
strategies. PAM wellvalidated tool
Reliability: Moderate
correlation of 0.4.
Ability to apply PAM
across all studies.
Precision: Significant
heterogeneity p< 0.1,
95% confidence
interval.

Study Findings
19 Randomized Control Trials
13 Quasi-Experimental designs
Interventions included weight
management, exercise, disease
management, & education.
Modalities included in-person
one-on-one coaching, interviews
via telehealth, & combination
Phone messages or telehealth
visits positively impacted patient
activation.
Videos, internet-based
interventions, smartphone app
showed no improvement in
patient activation.
Mean Patient Activation Measure
(PAM) scores: 59.1-82.5
baseline, 58.9-84.39
postintervention.
6 month follow-up showed
significant improvement in
patient activation in 16 studies.
12 month follow-up: additional 7
studies showed a significant
improvement in patient
activation.

Conclusions
Patient activation is not
significantly improved solely by
participation in self-management
interventions.
Interventions that are tailored to
pre-intervention activation levels
improve patient activation
significantly.
Improvements in patient activation
are most likely to occur when an
interdisciplinary team is included.
Teams including physicians,
nurses, allied health providers,
educators, patient navigators, &
care managers may improve
patient activation and provide cost
savings.
Future research should include
interdisciplinary teams, social
support, and in-person interactions.
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Brief Reference, Type of Study,
Quality rating
Article 6: Gholami, M., Talaei, A. A.,
Tarrahi, M. J., Taqi, F. M., Galehdar, N.,
& Pirinezhad, P. (2021). The effect of
self-management support program on
patient activation and inner strength in
patients with cardiovascular disease.
Evidence Level: II – Quasi-experimental
Quality: A – High quality – consistent,
generalizable results, adequate control,
sample size may be insufficient for
strength of study, consistent
recommendations, definitive conclusions

30
Methods
Design: Quasiexperimental, pretestposttest design
Sample: 86 patients in
cardiac care wards from
June 2017-May 2018, 18-65
yrs., cardiovascular disease
(CVD) diagnosis > 1yr.,
hospitalization d/t CVD, no
cognitive problems,
residence in Lorestan
province, read/speak
Persian, access to phone,
receiving routine medical
care.
Setting: teaching hospital
affiliated with Lorestan
University of Medical
Sciences, Western Iran.
Framework: Inner Strength
Theory, Continuous Care
Model
Measures: 13-item Patient
Activation Measure (PAM),
inner strength scale (ISS)
Analysis Plan: t-test for
normally distributed
variables, Chi-square test for
nominal/categorical
variables, normality
measured using
Kolmogorov-Smirnov test,
paired t-test for
pretest/posttest impact of
support program, P<0.05.
Procedure: 3 month nurseled self-management
support program
administered to 38 in
intervention group.

Threats to Validity/
Reliability
Conclusion Validity:
Moderate sample size,
increases likelihood of
Type II errors.
Internal Validity:
Design limits
confirmation of
activation promotion
as a result of
administering the
program, external
variables are not
controlled.
External Validity:
Sample consists of
symptomatic,
seeking/requiring
continuous postdischarge care, may
not be generalizable.
Construct Validity:
Study adequately
measured intended
outcomes.
Reliability:
Translation of PAM
tool into Persian may
limit reliability.
Precision:
Statistically
significant difference
in mean score of
patient activation
(P.001) in both groups
No statistical
significance in mean
score of inner strength
between the two
groups (P<0.104)

Study Findings
Low levels of patient activation
at baseline in both groups.
Statistically significant
differences between mean scores
of patient activation between
groups (P<.001).
Within-group analysis indicated
significant improvement in
patient activation in the
intervention group (P<.001).
Between-group analysis showed
no statistically significant
differences in means of inner
strength (P<.104).
Within-group analysis indicated
significant increase in inner
strength in the intervention group
(P<.001), and no significant
improvement in the comparison
group (P<.150).

Conclusions
Self-management support for
patients with CVD after their
discharge may not promote inner
strength but significantly improves
activation level.
Lowest initial activation levels
demonstrate patients at risk of
failing to control their health status
and disease during hospitalization.
An increase in self-reported PAM
score is associated with changes in
self-care behaviors, promotes
health decisions, and adherence to
symptom control behaviors.
Implementation and effectiveness
of self-management support
programs are highly variable based
on previous research.
Patient condition, continuation of
interactions, and content of selfmanagement program are
important.

PATIENT ACTIVATION
Brief Reference, Type of Study,
Quality rating
Article 7: Tecson, K. M., Bass, K.,
Felius, J., Hall, S. A., Jamil, A. K., &
Carey, S. A. (2018). Patient “activation”
of patients referred for advanced heart
failure therapy.
Evidence Level: II – Quasi-experimental
Quality: C – Low quality/major flaws –
little evidence without outside variable
control, insufficient sample size,
outcomes not specified, conclusions
cannot be drawn based on this study.
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Methods
Design: Prospective,
Observational
Sample: 196 patients: 133
selected for advanced HF
therapy, 63 not selected
Setting: Baylor University
Medical Center
Framework: N/A
Measures: Patient
activation, anxiety,
depression
Analysis Plan: Two-sample
t test, Wilcoxon Rank Sum
tests, Chi-square tests, &
Fisher’s Exact tests
Procedure: 10-item Patient
Activation Measure (PAM)
Questionnaire, anxiety and
depression measured by
hospital anxiety and
depression scale (HADS).

Threats to Validity/
Reliability
Conclusion Validity:
No limitations were
listed in the study.
Internal Validity:
Self-reporting may
cause bias; advanced
therapy intervention
could contribute to
outcomes.
External Validity:
May not be
generalizable to
populations other than
those receiving
advanced HF therapy.
Construct Validity:
Measured intended
outcomes.
Reliability: The
Patient Activation
Measure is a reliable
tool.
Precision: No
statistical significance
between PAM levels
and patient
characteristics
(p>.28), except
COPD (p=0.04) which
was associated with
higher rates of low
activation.
Statistically
significance between
PAM levels for those
selected for advanced
therapy vs not
(p=0.02)

Study Findings
Statistically higher proportion of
males accepted for therapy than
women (p=0.04).

Conclusions
Patients referred for advanced
heart failure therapy have higher
activation than those who are not
selected.

Neither anxiety nor depression
levels differed by selection status
(p=0.30 therapy, p=0.40 no
therapy).

Patients with activation have
poorer health literacy and often
require skilled care.

Those not selected for advanced
HF therapy were 4x more likely
to have lower activation.

The PAM tool may be an
important tool in identifying
patients at high risk of mortality.

Those selected had higher
prevalence of being categorized
in the two highest activation
levels than those not selected.

Patients with high activation are
more likely to be approved for
advanced therapy, so it is critical to
be highly engaged and activated.

Mortality at 1-year increased in
those not selected for therapy
(29%) v. selected (15%)(p=0.10).

The need for targeted interventions
to improve patient activation and
engagement was demonstrated in
this study.

Participants in the intervention
group had significant increases in
PAM scores from baseline to 6
months and fewer
hospitalizations.
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Brief Reference, Type of Study,
Quality rating
Article 8: Dumitra, T., Ganescu, O., Hu,
R., Fiore, Jr., J. F., Kaneva, P., Mayo, N.,
Lee, L., Liberman, A. S., Chaudhury, P.,
Ferri, L., & Feldman, L. S. (2021).
Association between patient activation
and health care utilization after thoracic
and abdominal surgery.
Evidence Level: III – Non-experimental
Quality: A/B – High/Good Quality –
Sufficient size for study design,
reasonable conclusions, describes how
data justify conclusions, identifies
sources to corroborate evidence, data and
knowledge are linked, consistent
recommendations made
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Methods
Design: Prospective cohort,
observational study
Sample: 653 patients
admitted for thoracic,
general, colorectal, and
gynecologic surgery
Setting: 2 hospital sites of
the McGill University
Health Care Center
(MUHC) tertiary care
hospital network, from
October 2017-January 2019.
Framework: Strengthening
the Reporting of
Observational Studies in
Epidemiology (STROBE)
Measures: 30-day postdischarge healthcare
utilization (emergency
department/outpatient clinic
visit, hospital readmission).
Secondary: length of stay,
30-day emergency
department visits,
readmissions, and postoperative complications
Analysis Plan: Chisquared/Fisher exact test, ttest/2-sided Mann Whitney
test, P<.05, 95% CI
Procedure: Patient
Activation Measure during
initial admission
immediately after surgery,
self-reported healthcare
utilization

Threats to Validity/
Reliability
Conclusion Validity:
adequate sample size
for study (n=650, 2sided testing, α=0.05,
80% power), wide
range of surgical
procedures. 59
patients lost to followup.
Internal Validity:
Observer bias was
minimized-outcomes
researcher unaware of
baseline
characteristics.
External Validity:
Construct Validity:
Primary outcomes
were adequately
measured.
Reliability: Patients
were informed at time
of enrollment;
sensitized
documentation of
unplanned healthcare
uses. Relied on
patient’s self-report of
healthcare use.
Precision:
Statistically
significant result
P<.001 for unplanned
healthcare utilization,
outpatient clinic visits
and P=.03 for ED
visits.

Study Findings

Conclusions

Unplanned healthcare utilization
at 30 days was significantly
higher in patients with low
patient activation [64(42%) v.
100(20%), P<.001].

Lower level of patient activation is
associated with higher risk of
unplanned healthcare utilization 30
days after thoracic and abdominal
inpatient surgery.

Hospital readmissions were
similar between high and low
patient activation [16(11%) v.
55(11%)].

Assessing patient activation level
preoperatively could identify
patients at risk of unplanned visits
and prompt interventions to
prepare and support them after
discharge.

Patients with low activation had
longer initial LOS [3.5(2-6) v.
3(1-5), P=.04].
A similar proportion of postoperative complications were
noted among both groups
[30(48%) v. 64(40%), P=0.29].
Multivariate regression showed
low level of activation was
associated with higher risk of
unplanned healthcare visits
(adjusted OR 3.15, 95% CI,
P<.001).
Low level of patient activation
was associated with increased ED
visits (adjusted OR 1.64, 95% CI,
P=.04) but not associated with
risk of readmission (adjusted OR
1.04, 95% CI, P=.90).
Low activation was associated
with increased risk of
complications (adjusted OR 1.63,
95%CI, P=.01).

Most of the work in patient
activation has been studied in
chronic conditions, this is the first
study in patients undergoing
surgery.
Patients with lower levels of
activation are at higher risk for
developing complications.

PATIENT ACTIVATION
Brief Reference, Type of Study,
Quality rating
Article 9: Dunlay, S. M., Griffin, J. M.,
Redfield, M. M., & Roger, V. L. (2017).
Patient activation in acute
decompensated heart failure.
Evidence Level: III – Nonexperimental
Quality: A/B – High/Good Quality Sufficient size for study design,
reasonable conclusions, data justified
conclusions, identifies sources to
corroborate evidence, data and
knowledge are linked, consistent
recommendations made
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Methods
Design: Prospective cohort
study, observational
Sample: 302 patients
currently hospitalized with
acute decompensated HF
(ADHF) meeting
Framingham Criteria from
January 2014-July 2015;
chronic HF, ≥ 20yrs.,
resident of 1 of 7
Southeastern Minnesota
counties.
Setting: Mayo Clinic,
Rochester, Minnesota
Framework: N/A
Measures: Length of stay,
discharge location, inpatient
mortality, 30-day postdischarge readmissions, 30day post-discharge mortality
Analysis Plan: Linear
regression models, MantelHanszel Chi-Squared test,
Cox proportional hazard
regression
Procedure: 13-item Patient
Activation Measure (PAM)
administered

Threats to Validity/
Reliability
Conclusion Validity:
Hospital mortality
should be replicated in
larger sample size.
Internal Validity:
Readmissions not at
Mayo facility was not
recorded in data.
External Validity:
Conducted in single
community, may not
be valid in other
geographic areas.
Construct Validity:
First study to
investigate
associations of
activation and
outcomes with
hospitalized ADHF
patients.
Reliability: Patient
Activated Measure®
is a reliable and
validated tool.
Precision:
Association between
patient activation and
30-day readmission
was not statistically
significant, P=.067,
95% confidence
interval.
No significant
association between
patient activation and
length of stay (𝛽=.06,
95% CI, P=.92).

Study Findings

Conclusions

Patient activation scores ranged
29-100.

Lower activation is associated with
higher 30-day mortality.

Patients less activated were older,
less educated, worse general and
financial satisfaction, and worse
health literacy.

Lowest activation level had more
than 6-fold increased risk of death
within 30 days of discharge.

Median length of stay was 4 (3-7)
days.
30-day readmission rate was
21.7%
30-day post-discharge mortality
rate was 7.0%.
Increase in proportion discharged
to skilled nursing facility with
decreasing activation (P<.001).
Increase in 30-day mortality with
decreasing activation (P=.003).

Most patients hospitalized with
ADHF lack skills, confidence, and
motivation to manage their health.
Those with lower activation are
less satisfied with their care, often
require skilled care on discharge,
and have higher 30-day mortality.

PATIENT ACTIVATION
Brief Reference, Type of Study,
Quality rating
Article 10: Hibbard, J. H., Stockard, J.,
Mahoney, E. R., & Tusler, M. (2004).
Development of the patient activation
measure (PAM): Conceptualizing and
measuring activation in patients and
consumers.
Evidence Level: III – Qualitative
Quality: A/B – High/Good Quality –
Decisions on tool creation and methods
were explicitly detailed, several stages
demonstrate verification of findings, data
is relevant, definitive conclusions drawn.
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Methods
Design: Pilot-study: 4
stages
Sample: Stage 4:
Convenience samples with
and without chronic illness
during initial stages,
national probability random
sample of 1,515, ≥45yrs.
Setting: Not explicitly
stated, United States.
Framework: Chronic
Illness Care Model
Measures: Assessing
activation and psychometric
properties
Analysis Plan: Rasch
methodology
Procedure: Pilot-test and
initial psychometric analysis

Threats to Validity/
Reliability
Conclusion Validity:
Adequate sample size,
first study on this tool.
Internal Validity:
Investigator bias –
creators of this tool
are conducting the
study to evaluate
efficacy; it is expected
to be valid and
reliable.
External Validity:
Outcomes measured
as intended.
Construct Validity:
Variables believed to
be related to activation
were examined for
relationship to
measured activation.
Results indicated
considerable evidence
for construct validity.
Reliability: Rasch
reliability for 22-item
PAM showed high
level of reliability
Precision: Precision
of item’s scale
location/calibration
estimated by the
item’s standard of
error. Precision of
each individual
respondent’s
estimated scale
location specified by
the standard error of
measurement of that
person.

Study Findings
Rasch measurement was used to
create interval-level,
unidimensional, probabilistic
Guttman-like scales from ordinal
data.
An individual’s location indicates
how activated the person is.
48% response rate during stage 4
study.
73% respondents reported 2 or
more chronic conditions.
Those with higher activation
reported significantly better
health (r=.38, p<.001) and have
lower rates of doctor office visits,
ER visits, and hospital nights (r=.07, p<.01).
Findings indicate a high degree
of construct and criterion
validity.
Patients with higher activation
are more likely to exercise
regularly, follow a low-fat diet,
eat more fruits and vegetables,
and not smoke.

Conclusions
Higher activation significantly
more likely to engage in
consumeristic behaviors.
Engaging patients to be an active
part of care is essential in quality
of care.
The Patient Activation Measure
appears to be a valid and reliable
instrument to measure activation.
The PAM tool may be useful for
designing interventions and
evaluating them.
This measure can be used in the
clinical setting to assess individual
patients to develop care plans
tailored to that patient and
integrate into their care.
Activation appears to involve 4
stages: believing the patient role is
important, having the confidence
and knowledge necessary to take
action, taking action to maintain
and improve one’s health, and
staying the course even under
stress.

PATIENT ACTIVATION
Brief Reference, Type of Study,
Quality rating
Article 11: Jacobson, A. F., Sumodi, V.,
Albert, N. M., Butler, R. S., DeJohn, L.,
Walker, D., Dion, K., Lin Tai, H. L., &
Ross, D. M. (2018). Patient activation,
knowledge, and health literacy
association with self-management
behaviors in persons with heart failure.
Evidence Level: III – Nonexperimental
Quality: A/B – High/Good Quality –
Reasonably consistent results, sufficient
sample size, data and knowledge is
meaningful.
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Methods
Design: Prospective crosssectional, correlational
Sample: Convenience
sample of 151 adults with
HF, ≥ 18yrs., established
outpatient center patient
(1mo. or longer), diagnosed
with any type of HF,
read/write English
Setting: 4 outpatient centers
of a large health system in
Northeast Ohio
Framework: N/A
Measures: HF selfmanagement: adherence to
medications, diet, exercise,
weight and symptom
monitoring, patient
activation
Analysis Plan: Correlation
and multiple regression,
α=0.05
Procedure: European Heart
Failure Self-Care Behaviour
Scale (EHFScBS), Patient
Activation Measure®

Threats to Validity/
Reliability
Conclusion Validity:
Adequate sample size
(n=150, power 0.80,
α=0.05).
Internal Validity:
Self-reported surveys
are subject to bias.
Cognitive function not
assessed. No
dedicated data
collector.
External Validity:
Convenience sample
limits generalizability
to other locations.
Excluding those
unable to read, write,
or speak English, or
chose not to
participate limits
generalizability.
Construct Validity:
Variables accurately
measured as stated.
Reliability: PAM tool
is reliable and
validated. Missing
data may influence
reliability. Those with
low literacy levels
may have left blanks.
Precision: Significant
correlation between
age (r=0.305,
P=.0007), patient
activation stage
(r=.281, P=.0008),
and heart failure selfmanagement.

Study Findings
Older age was associated with
higher degree of selfmanagement (p=.0007).
Patient activation was the only
variable positively associated
with self-management (p=.0008).
A significant association between
health literacy and HF knowledge
was observed (r=.292, p<.0001).
No correlation of a mediation
effect of HF knowledge on
patient activation (r=.030,
P=.24).

Conclusions
There is a positive relationship
between patient activation and selfmanagement behaviors in HF and
other chronic conditions.
Patient activation does not increase
HF knowledge and HF knowledge
does not improve selfmanagement.
Patient activation level and patient
age, but not heath literacy level or
HF knowledge positively relate to
HF self-management behaviors.

PATIENT ACTIVATION
Brief Reference, Type of Study,
Quality rating
Article 12: Kearns, R., Harris-Roxas, B.,
McDonald, J., Song, H. J., Dennis, S., &
Harris, M. (2020). Implementing the
patient activation measure (PAM) in
clinical settings for patients with chronic
conditions: a scoping review.
Evidence Level: III - Exploratory
Quality: A/B – High/Good Quality Reasonable results, sufficient sample
size of articles, data regarding sample
size in each article was not provided.
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Methods
Design: Scoping review
methodology
Sample: 21 articles,
published in English, 20042017, adult ≥ 18yrs.
patients with chronic
conditions, PAM-tailored
intervention.
Setting: Organisation for
Economic Cooperation and
Development countries,
USA and UK
Framework: N/A
Measures: PAM-tailored
interventions
Analysis Plan: Preferred
Reporting Items for
Systematic Reviews and
Meta-Analysis
Procedure: Insignia Health
website and Medline
database searched

Threats to Validity/
Reliability
Conclusion Validity:
Sample sizes of
studies not provided;
article sample size
sufficient for analysis.
Internal Validity: No
analysis of bias
External Validity:
All intervention
studies were in USA
or UK, lack of
diversity, cultural and
demographic
background may limit
generalizability.
Construct Validity:
Analyzed intended
measures.
Reliability: Quality of
the studies nor
interventions were
assessed.
Precision: No
statistical analysis
provided.

Study Findings

Conclusions

PAM has been used to tailor
interventions including:
motivational interviewing, health
coaching, goal setting,
development of care and selfmanagement plans, provision of
health information, hospital to
home transition, care
coordination, self-management,
and readmission prevention
programs.

PAM is used to help clinicians
understand how to effectively
coach, tailor support, health
information, and advance based on
activation level.

Enablers and barriers to PAM
implementation include:
organization & leadership
support for patient activation,
culture changes to patient,
professional, and provider roles,
clinician engagement & “buy-in”
about the need for patientcentered care, perceptions about
the value of PAM, confidence &
ability to deliver intervention.
The effect of PAM-tailored
interventions on patient behaviors
differed across studies.
Declines in hospital admissions,
readmissions, and hospital days
were reported.

Programs such as care
coordination, health coaching, selfmanagement interventions, inhome/hospital outreach programs
should be tailored to patient
activation based on PAM.
PAM-tailored interventions may
have the potential to improve
patient behaviors.
PAM is being used to tailor and
differentiate care for patients with
chronic conditions in a variety of
settings.
The PAM tool does not have
widespread use outside of the USA
or UK or in patients from
culturally and linguistically diverse
backgrounds.
The effect of PAM-tailored
interventions on clinical and
patient behaviors was unable to be
determined based on this analysis.

PATIENT ACTIVATION
Brief Reference, Type of Study,
Quality rating
Article 13: Kinney, R. L., Lemon, S. C.,
Person, S. D., & Pagoto, S. L. (2015).
The association between patient
activation and medication adherence,
hospitalization, and emergency room
utilization in patients with chronic
illnesses: a systematic review.
Evidence Level: III – Systematic review
of non-experimental studies without
meta-analysis
Quality: A/B – High/Good Quality –
Small sample size, decision justified,
admits to bias, reasonable conclusions,
identifies sources to corroborate
evidence
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Methods
Design: Systematic review
of observational cohort
design without metaanalysis
Sample: 10 articles
published 2007-2014: adults
≥ 18yrs., with a diagnosis of
a chronic medical condition
(heart disease, diabetes,
COPD, depression),
published in English, patient
activation and PAM-13,
PAM-8, or PAM-22 scale
Setting: United States
Framework: N/A
Measures: Association
between PAM scores and at
least one other outcomes of
interest (hospitalization,
emergency room utilization,
medication adherence).
Analysis Plan: Downs and
Black criteria for
methodological quality
Procedure: Ovid,
MEDLINE, PsychINFO,
PubMed, Cochrane
Database of Systematic
Reviews, CINAHL, ISI
Web of Science, Health and
Psychosocial Instruments

Threats to Validity/
Reliability
Conclusion Validity:
Small sample size,
limited to
observational studies
conducted by
developers of PAM.
Internal Validity:
Publication bias –
6/10 studies were
conducted by
developers of PAM.
External Validity:
Studies were limited
to only English, may
limit generalizability
to other countries.
Construct Validity:
Other measures that
may examine
constructs of
activation were not
included.
Heterogeneity did not
allow meta-analysis to
be performed.
Reliability: PAM is
the most widely
accepted measure of
patient activation.
Precision: Significant
associations for
patient activation and
ER utilization and
readmissions.
Not significant for
medication adherence.

Study Findings
5 studies examined patient
activation and hospitalization. 4/5
demonstrated an inverse
association between PAM score
& hospitalization.
Chronic cardiopulmonary illness
reported lower PAM scores &
were 2x more likely to be
hospitalized within 30 days
(IRR=1.93, CI 95%).
3/3 studies found significant
associations with lower PAM
score and increased likelihood of
utilizing the ER (IRR=1.68, 95%
CI).
3/7 studies demonstrated low
PAM scores were 2.5x more
likely to have self-reported
missing 2 or more days of
medications in past 7 days
(OR=2.65, 95% CI, P<.001).

Conclusions
Patient activation is associated
with reduced hospitalization and
emergency room utilization.
Patient activation is modifiable,
changes over time, and may be
associated with better utilization.
This is the first review that
synthesized PAM literature on
several healthcare utilization
outcomes.
Strong evidence that lower
activation in chronically ill patients
is associated with higher rates of
hospitalization than higher
activation.
Association of patient activation
and medication adherence is
inconclusive.

PATIENT ACTIVATION
Brief Reference, Type of Study,
Quality rating
Article 14: Prey, J. E., Qian, M.,
Restaino, S., Hibbard, J., Bakken, S.,
Schnall, R., Rothenberg, G., Vawdrey,
D.K., & Creber, R. M. (2016).
Reliability and validity of the patient
activation measure in hospitalized
patients.
Evidence Level: III – Exploratory study
Quality: A/B- High/Good quality –
discusses enhancement of the overall
inquiry in sufficient detail, verified
methodological coherence, addresses
potential generalizability concerns, data
and knowledge is linked to relevant
literature, consistent conclusions
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Methods
Design: Exploratory
analysis
Sample: 100 participants
from cardiology and
oncology units, ≥18yrs.,
English speaking
Setting: Large, urban,
academic medical center
Framework: N/A
Measures: Patient
activation, sample
characteristics, quality of
life, health literacy
Analysis Plan: Internal
consistency using
Cronbach’s alpha, forward
and backward stepwise
selection, Wilcoxon ranksum tests to analyze planned
vs unplanned, Spearman
ranked correlation for
convergent validity,
ANOVA for strength of
association between
PROMIS scores and
activation level.
Procedure: PAM-13 tool
administered to planned vs
unplanned admissions

Threats to Validity/
Reliability
Conclusion Validity:
Small sample size,
analysis of predictors
of low activation may
have been too
underpowered to
detect differences.
Internal Validity:
Did not include nonEnglish speaking
patients.
External Validity:
Conducted at a large,
urban, academic
center with a diverse
population, makes it
generalizable.
Construct Validity:
Demonstrated validity
and reliability of
measuring patient
activation.
Reliability:
Demonstrated PAM is
a reliable measure of
patient activation.
Precision: The PAM
demonstrated
adequate internal
consistency (Cronbach
α=0.81).
Statistically
significant difference
in PAM-13 levels of
planned compared to
unplanned admissions
(p=.0001).

Study Findings

Conclusions

Unplanned admissions were more
likely to have low activation
(adjusted OR=5.8, p=.008).

There is a significant difference in
PAM levels between hospitalized
patients with unplanned compared
to planned admissions.

Higher proportion of participants
with low activation in the
unplanned admission group for
both oncology and cardiology
(p=.007, p=.047).
The PAM-13 was modestly
correlated (p<.001) with each of
the three PROMIS Global Health
components (global, physical,
and mental health).
ANOVA demonstrated lower
scores on PROMIS measures,
associated with low activation.

This supports previous research
that admission type predicts low
patient activation.
There is modest correlation
between PAM-13 levels and
quality of life.
The PAM-13 is a reliable and valid
measure to be used in the inpatient
setting. It has also shown
admission type is an important
predictor of patient activation.
Understanding patient activation is
important for optimizing patient
communication.

PATIENT ACTIVATION
Brief Reference, Type of Study,
Quality rating
Article 15: Roberts, N. J., Kidd, L.,
Dougall, N., Patel, I. S., McNarry, S., &
Nixon, C. (2016). Measuring patient
activation: The utility of the patient
activation measure within a UK context
– Results from four exemplar studies and
potential future applications.
Evidence Level: III – Exploratory,
Explanatory mixed method
Quality: C – Studies contribute little to
overall findings, small sample size,
missing data, reliability of tool in this
setting is undetermined, discussed
limitations to each study.
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Methods
Design: Exploration of 4
exemplar studies: 1.
Observational prospective
cross sectional, 2 and 3.
Secondary retrospective
analysis, 4. Two phased
mixed method
Sample: 1. 40 COPD
patients, 2. 29 COPD
patients, 3. 274 attending
pulmonary rehab., 4. 20
stroke patients
Setting: UK
Framework: N/A
Measures: explore and
describe PAM scores in
populations with stroke or
COPD
Analysis Plan: Descriptive
statistics, ANOVA w/ post
hoc Tukey HSD
comparisons, repeated
measures ANOVA w/
Greenhouse-Geisser
correction, Mann Whitney,
Chi-Square
Procedure: PAM tool
administered 1. Before and
after appointment, 2. Before
and after self-management
program, and at 3-, 6-, and
12-months post, 3. Prior to
pulmonary rehab program,
4. Prior to qualitative
interview on selfmanagement needs

Threats to Validity/
Reliability
Conclusion Validity:
Small sample for all 4
studies. Studies were
significantly
underpowered.
Internal Validity: No
control group, some
data missing for
variables, convenience
samples.
External Validity:
Single site studies,
only conducted in UK.
Likely not
generalizable.
Construct Validity:
PAM score was not
assessed postintervention in
exemplar 4.
Reliability: PAM tool
has not been studied in
UK, missing data and
lack of access to data
may limit reliability.
Precision: Significant
differences in PAM
scores pre- and postintervention when data
available.

Study Findings

Conclusions

1. Significant difference in PAM
between respiratory clinic
patients & those attending
pulmonary rehab (p=0.023). No
significant difference between
disease severity (p=0.389).

PAM can be used as an outcome
measure to measure effectiveness
of interventions.

2. Median PAM scores higher
post-program but dropped at 3
months post. Significant
differences between means at
different time points (F=7.164,
p=0.002). Significant differences
between baseline and postprogram (p=0.001).

Most of data regarding PAM has
only been conducted in the United
States, not the UK, may limit
feasibility in other countries.

3. Significant differences
between baseline PAM scores
and 6 (p<0.001) and 12 months
(p<0.001).
4. No significant differences in
PAM scores when comparing
gender and Modified Rankin
Scores (level of disability).
Qualitative interviews reflected
characteristics of lower PAM
levels (1 and 2).

PAM can be useful to inform
tailoring of interventions.

Tool should not be used in
isolation, good demographic and
patient history need to be obtained.

PATIENT ACTIVATION
Brief Reference, Type of Study,
Quality rating
Article 16: Bishop-McWain, T. (2019).
Reducing 30-day heart failure
readmission rates using patient activation
scores: An interprofessional approach.
Evidence Level: V – Organizational
Experience/Quality Improvement
Quality: B – Good quality – clear
objectives in single setting, quality
improvement methods used but no
statistical analysis, reasonable
recommendations with some reference to
scientific evidence from literature review
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Methods
Design: Quality
Improvement Study
Sample: 107 HF patients
identified with lowactivation (level 1 and 2 on
PAM survey), age ≥18
Setting: OSF Healthcare St.
Joseph Medical Center,
Illinois
Framework: Plan, Do,
Study, Act
Measures: 30-day HF
readmissions
Analysis Plan: Chart audit,
Microsoft Excel pivot table,
Insignia Health Patient
Activation Measure-10
(PAM-10)
Procedure:
Interprofessional HF team
approach applied to lowactivated patients

Threats to Validity/
Reliability
Conclusion Validity:
reasonable, addresses
limitations, small
sample size, small
community hospital.
Internal Validity:
many
inaccurately/missed
HF diagnosis coding,
some interprofessional
team members not
always included in
intervention, other
variables could impact
results, no control.
External Validity:
May not be applicable
to other healthcare
centers without
adequate resources.
Construct Validity:
activation level never
reassessed to
determine intervention
effectiveness on
readmission.
Reliability: only 70%
completed PAM-10
survey, HF
coordinator not always
present for
intervention
Precision: No
statistical analysis
available

Study Findings

Conclusions

HF readmission rate declined for
the 1st time in 3 years.

Tailored interdisciplinary care
reduces 30-day HF readmission
rate in patients with low-activation.

HF readmission rate dropped
below project goal of 16% to 1115% during data collection
period.
Importance of stratifying patients
based on activation level was
inclusive based on patient
feedback received during
interview.
Sustainability may be an issue
due to lack of engagement by
staff and time constraints to
administer the PAM survey.
HF coordinator role had no
formal job description, new role
in organization

Palliative care as an
interdisciplinary team member
could significantly contribute to
reduced readmissions, was not
included in this study.
Difficult to determine if
readmissions were related to
activation level since this was
never reassessed or if
interprofessional intervention
impacted readmission rate, no
statistical analysis.
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Appendix B
13-item Patient Activation Measure®
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Appendix C
Levels of Patient Activation
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Appendix D
Individualized Coaching Plan
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Appendix E
Project Timeline

October 2021

14

Obtain SRMH’s Evidence-Based Practice and Research
Shared Governance Council approval.

November 2021

12

UofSC DNP Project Proposal Defense Presentation

23

Submit required forms to SRMH IRB for review and
approval.

December 2021

31

Obtain research license from Insignia Health for the use of
the Patient Activation Measure® tool & paid $150 fee

January 2022

4

SRMH IRB approval obtained

11

UofSC eIRB submission

18

Provide training to HF Nurse Navigator on PAM® survey

20

UofSC eIRB approval obtained

27

Project Implementation. Begin data collection

28

Provide training to CCM team on PAM® survey & coaching
recommendations

May 2022

18

Begin demographic data collection & analysis

June 2022

1

Begin final paper revision.

3

Project completion. Last participant enrollment

7

Complete data collection & analysis

22

UofSC DNP Final Defense

July 2022

August 2022

TBD Disseminate study findings to Insignia Health
TBD Submit final deliverable to SRMH Evidence-Based Practice
& Research Shared Governance Council
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Appendix F
Sample Population Descriptive Statistics

Variable

n

%

1

10

13.33

2

20

26.67

3

34

45.33

4

11

14.67

1

4

5.33

2

10

13.33

3

16

21.33

4

14

18.67

Missing

31

41.33

Male

29

38.67

Female

46

61.33

Married

32

42.67

Single

11

14.67

Widowed

16

21.33

Divorced

12

16.00

Life Partner

1

1.33

Separated

3

4.00

Some college, no degree

2

2.67

High School graduate

4

5.33

12th grade

2

2.67

Master's degree

1

1.33

Some college

1

1.33

8th Grade

1

1.33

10th grade

2

2.67

11th Grade

2

2.67

11th Grade/GED

1

1.33

12th Grade

2

2.67

PAM Level

Re-Survey PAM Level

Gender

Marital Status

Education Level

PATIENT ACTIVATION
Missing

46
57

76.00

0

63

84.00

1

11

14.67

2

1

1.33

0

63

84.00

1

12

16.00

0

31

41.33

1

1

1.33

2

1

1.33

3

1

1.33

41

54.67

0

27

36.00

1

5

6.67

2

2

2.67

41

54.67

30-Day Readmission

30-Day ER Visit

90-Day Readmission

n/a
90-Day ER Visit

n/a
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Appendix G
Statistical Results

Figure G1
The means of PAM Level and Re-Survey PAM Level with 95.00% CI Error Bars

Table G1
Two-Tailed Paired Samples t-Test for the Difference Between PAM Level and Re-Survey PAM
Level
PAM Level
M
SD

Re-Survey PAM Level
M
SD

t

p

2.50
0.82
2.91
0.96
-2.86
.006
Note. N = 44. Degrees of Freedom for the t-statistic = 43. d represents Cohen's d.

d
0.43
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Figure G2
Ranked values of PAM Level and Re-Survey PAM Level

Table G2
Analysis of Variance Table for PAM Level by Marital Status
Term
Marital Status
Residuals

SS

df

F

p

ηp 2

0.91
58.87

5
69

0.21

.955

0.02

Table G3
Mean, Standard Deviation, and Sample Size for PAM Level by Marital Status
Combination

M

SD

Married
2.69
0.82
Single
2.55
1.04
Widowed
2.44
0.96
Divorced
2.67
1.07
Life Partner
3.00
Separated
2.67
0.58
Note. A '-' indicates the sample size was too small for the statistic to be calculated.

n
32
11
16
12
1
3
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Table G4
Analysis of Variance Table for PAM Level by Age
Term
Age
Residuals

SS

df

F

p

ηp 2

33.33
26.46

41
33

1.01

.488

0.56

Table G5
Mean, Standard Deviation, and Sample Size for PAM Level by Age
Combination
33
37
38
40
44
45
46
52
54
55
56
58
59
60
61
62
63
64
65
66
67
69
71
72
73
74

M

SD

n

4.00
3.00
3.00
3.50
3.00
3.00
3.00
2.50
2.33
2.00
3.00
3.00
2.00
4.00
2.00
1.67
2.33
2.00
3.00
3.50
2.50
3.00
2.50
3.33
2.00
1.00

0.71
0.00
0.71
0.58
1.15
0.58
0.71
0.71
0.00
0.58
0.58
-

1
1
1
2
1
1
2
2
3
1
1
1
1
1
1
3
3
1
1
2
2
2
4
3
1
1
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75
3.00
1.41
76
2.00
1.41
77
2.75
1.26
79
1.00
80
2.88
0.99
81
4.00
82
2.00
1.41
83
4.00
84
3.00
85
1.50
0.71
86
2.00
87
2.33
0.58
88
2.00
89
3.00
92
3.00
95
1.00
Note. A '-' indicates the sample size was too small for the statistic to be calculated.

2
2
4
1
8
1
2
1
1
2
1
3
1
1
1
1

Table G6
Analysis of Variance Table for PAM Level by 90-Day Readmission
Term
90-Day Readmission
Residuals

SS

df

F

p

ηp 2

3.99
55.79

4
70

1.25

.297

0.07

Table G7
Mean, Standard Deviation, and Sample Size for PAM Level by 90-Day Readmission
Combination

M

SD

1
3.00
0
2.39
0.92
2
2.00
3
2.00
n/a
2.80
0.87
Note. A '-' indicates the sample size was too small for the statistic to be calculated.

n
1
31
1
1
41
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Table G8
Analysis of Variance Table for PAM Level by Gender
Term
Gender
Residuals

SS

df

F

p

ηp 2

1.88
57.90

1
73

2.37

.128

0.03

SD

n

Table G9
Mean, Standard Deviation, and Sample Size for PAM Level by Gender
Combination

M

Male
2.41
0.91
Female
2.74
0.88
Note. A '-' indicates the sample size was too small for the statistic to be calculated.

29
46

Table G10
Analysis of Variance Table for PAM Level by Education Level
Term
Education Level
Residuals

SS

df

F

p

ηp 2

8.19
8.25

9
8

0.88

.575

0.50

Table G11
Mean, Standard Deviation, and Sample Size for PAM Level by Education Level
Combination

M

SD

n

Some college, no degree
3.00
1.41
High School graduate
2.75
1.26
12th grade
1.00
0.00
Master's degree
3.00
Some college
2.00
8th Grade
2.00
10th grade
2.50
0.71
11th Grade
2.50
0.71
11th Grade/GED
3.00
12th Grade
3.50
0.71
Note. A '-' indicates the sample size was too small for the statistic to be calculated.

2
4
2
1
1
1
2
2
1
2
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Table G12
Analysis of Variance Table for PAM Level by 30-Day ER Visit
Term
30-Day ER Visit
Residuals

SS

df

F

p

ηp 2

0.01
59.77

1
73

0.02

.901

0.00

Table G13
Mean, Standard Deviation, and Sample Size for PAM Level by 30-Day ER Visit
Combination

M

SD

n

0
2.62
0.91
1
2.58
0.90
Note. A '-' indicates the sample size was too small for the statistic to be calculated.

63
12

Table G14
Analysis of Variance Table for PAM Level by 30-Day Readmission
Term
X30_Day_Readmission
Residuals

SS

df

F

p

ηp 2

0.53
59.26

2
72

0.32

.728

0.01

Table G15
Mean, Standard Deviation, and Sample Size for PAM Level by 30-Day Readmission
Combination

M

SD

0
2.60
0.91
1
2.73
0.90
2
2.00
Note. A '-' indicates the sample size was too small for the statistic to be calculated.

n
63
11
1

Table G16
Analysis of Variance Table for PAM Level by 90-Day ER Visit
Term
90-Day ER Visit
Residuals

SS

df

F

p

ηp 2

6.28
53.50

3
71

2.78

.047

0.11
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Table G17
Mean, Standard Deviation, and Sample Size for PAM Level by 90-Day ER Visit
Combination

M

SD

0
2.36
0.87
1
2.80
0.84
2
1.50
0.71
n/a
2.83
0.87
Note. A '-' indicates the sample size was too small for the statistic to be calculated.

Figure G3
Means of PAM Level by 90-Day ER Visit with 95.00% CI Error Bars

n
28
5
2
40
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Appendix H
Steps of the Intervention

